Cullinan Therapeutics (CGEM) Stock Price & Financial Analysis
Cullinan Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Cullinan Therapeutics
What is the current stock price for CGEM?
As of the latest trading session, CGEM stock trades at $14.43. The 52-week range is $5.68–$16.74, with a day range of $13.51–$14.62.
What is the P/E ratio for CGEM?
The P/E ratio (Price-to-Earnings) for CGEM is shown in the Key Statistics section. This valuation metric helps compare Cullinan Therapeutics, Inc. to industry peers.
Does CGEM pay dividends?
Cullinan Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for CGEM?
Based on 10 analysts, the consensus for CGEM is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of CGEM?
Cullinan Therapeutics's market capitalization is $854.3M, classifying it as a small-cap company. Cullinan Therapeutics operates in the Healthcare sector within the Biotechnology industry.